Cellectar Biosciences Inc (CLRB)

[Crusader]

Yes, they know how to play,

But how long until they do not have to play that game, because share demand spikes up on clinical trial news- great news for patients and investors?

Previously you estimated another year or so? They can burn mucho cash, right. This year 2018, CLRB WILL HAVE 2 or 3 clinical trials recruiting and administering 2 or 3 products. RESULTS?

Not in 2018...CLR 131 could be the first, if only diagnostically, to offer actual profits in 2020?

So when will greed succeed in supporting CLRB share price: mid-2019?

THAT WOULD BE AFTER THE RS GAME IS OVER A THIRD TIME...BUT HEY THAT IS WHAT COMMON SHARES ARE FOR WITHOUT A WHITE KNIGHT VC COMPANY OR A FAT ASS MERGER PARTNER!!!

What say you, Koly, on such a timeline and most likely fuel source for cash burn?